ORIGINAL RESEARCH article
Front. Bioeng. Biotechnol.
Sec. Cell and Gene Therapy
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1645499
This article is part of the Research TopicStem Cells and Kidney Regeneration: Transforming Renal MedicineView all 4 articles
OSR1 and SIX2 Drive Divergent Transcrip7onal Programs in Human Kidney Cells: Implica7ons for Regenera7on and Tumorigenesis
Provisionally accepted- 1Pediatric Nephrology, Dana Dwek Children's Hospital, Tel Aviv Medical Center, Israel, TEL AVIV, Israel
- 2Gray Faculty of Medical & Health Sciences, Tel Aviv University, Israel, TEL AVIV, Israel
- 3Laboratory for Human Kidney Development Research under the Center Of Regeneration And Longevity (CORAL), Tel Aviv Medical Center, Israel, TEL AVIV, Israel
- 4Pediatric Stem Cell Research Institute and Division of Pediatric Nephrology, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel, RAMAT GAN, Israel
- 5Chaim Sheba Academic Medical Center, RAMAT GAN, Israel
- 6Tissue Engineering Research Laboratory, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel., RAMAT GAN, Israel
- 7Kidney Research Lab, The Institute of Nephrology and Hypertension, Sheba Medical Center, Tel-Hashomer, Israel, RAMAT GAN, Israel
- 8Sagol Center for Regenerative Medicin, Tel Aviv University, Israel, TEL AVIV, Israel
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: During human nephrogenesis, nephron progenitor cells (NPCs) generate approximately one million nephrons. Postnatally, the silencing of key kidney progenitor genes results in the depleJon of this progenitor pool, limiJng the mature kidney's capacity for regeneraJon. Concurrently, the rising incidence of end-stage kidney disease underscores the urgent need for innovaJve regeneraJve strategies. Methods: We employed lenJviral vectors to ectopically induce key kidney progenitor genes—OSR1 and SIX2, individually or together—in primary adult human kidney (hAK) cells. We then analyzed the cellular and molecular consequences through morphological assessment, funcJonal assays, in vivo transplantaJon studies, and comprehensive transcripJonal profiling. Results: OSR1 and SIX2 induced disJnct reprogramming programs with differenJal funcJonal outcomes. SIX2 overexpression maintained epithelial morphology while significantly enhancing proliferaJon and clonogenic efficiency. TranscripJonally, SIX2 established epithelializaJon and cell cycle networks, downregulaJng proximal tubule markers, while upregulaJng distal nephron markers and proliferaJon genes. In vivo, SIX2-expressing cells formed organized tubular structures with disJnct luminal architecture in a proof-of-concept model.. In contrast, OSR1 overexpression induced morphological changes and acJvated developmental morphogeneJc pathways including epithelial tube morphogenesis and canonical Wnt signaling, but did not enhance proliferaJon and showed minimal tubulogenic capacity in vivo. Unexpectedly, OSR1 overexpression led to malignant transformaJon in one clone, exhibiJng Wilms' tumor-like features including expression of kidney developmental markers (i.e. SIX2, NCAM1, WT1) and mesenchymal phenotype. Conclusion: Our findings suggest that SIX2 overexpression in primary human adult kidney cells funcJonally confers enhanced self-renewal and tubulogenic capacity while transcripJonally Inducing a proximal to distal tubular cell diversion with maintained proliferaJve programs. In contrast, OSR1 acJvates broader developmental morphogeneJc networks but poses potenJal oncogenic risks. The malignant transformaJon observed with OSR1 overexpression provides insight into potenJal cellular origins of Wilms' tumor and raises important safety consideraJons for regeneraJve medicine approaches involving developmental gene inducJon in adult kidney cells.
Keywords: Nephron progenitor cell (NPC), kidney development, reprogramming, Wilms' tumor, human adult kidney, kidney regeneration
Received: 11 Jun 2025; Accepted: 02 Sep 2025.
Copyright: © 2025 Pode-Shakked, Cohen-Zontag, Omer, Vax, Harari-Steinberg, Pleniceanu and Dekel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Benjamin Dekel, Pediatric Stem Cell Research Institute and Division of Pediatric Nephrology, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel, RAMAT GAN, Israel
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.